Results 121 to 130 of about 4,273 (136)

Biochemical analysis reveals aberrant and variable Immunoglobulin M composition in Waldenström macroglobulinemia and IgM monoclonal gammopathy of unknown significance. [PDF]

Front Immunol
Oskam N, Verhaar W, Ooijevaar-de Heer P, Amaador K, Derksen NIL, Keijzer S, Kersten MJ, Streutker M, Vos JMI, Rispens T.   +9 more
europepmc   +1 more source

From interference to insight: pseudo-lipidemia led to the diagnosis of Waldenström macroglobulinemia. [PDF]

BMC Cardiovasc Disord
Wang D, Li P, Su W, Hou L, Han J, Zhang Y, Liu L, Mu D, Xia L, Qiu L.   +9 more
europepmc   +1 more source

Waldenström Macroglobulinemia: The Role of TP53 Mutations in Disease Progression and Therapeutic Response. [PDF]

Curr Issues Mol Biol
Kampitsi DD, Theotokis P, Evangelidis P, Meditskou S, Manthou ME, Dermitzakis I.   +5 more
europepmc   +1 more source

Progression of IgM Monoclonal Gammopathy of Renal Significance (MGRS) to Symptomatic Waldenström Macroglobulinemia: A Case Report. [PDF]

Cancer Rep (Hoboken)
Ito K, Shimoyamada H, Hirano K, Sekiguchi N.   +3 more
europepmc   +1 more source

Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenström macroglobulinemia. [PDF]

Blood Adv
Branagan AR, Mo C, Lei M, Gustine JN, Yee AJ, O'Donnell E, Castillo JJ, Nadeem O, Flynn C, Bernstein Z, Nakamoto-Matsubara R, Meid K, Verma R, Hunter ZR, Guerrera ML, Alter G, Burke J, Harrington C, Agyemang E, Gammon M, Lively K, Packer L, Horick N, Laubach J, Mitsiades CS, Munshi N, Anderson KC, Treon SP, Richardson PG, Raje NS, Sarosiek SR.   +30 more
europepmc   +1 more source

Correction to "Salvage treatment after covalent BTKi failure: An unmet need in clinical practice in Waldenstrom macroglobulinemia". [PDF]

Hemasphere
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Report of consensus Panel 4 from the 11th International Workshop on Waldenstrom's macroglobulinemia on diagnostic and response criteria

Seminars in Hematology, 2023
E Kimby
exaly  

Hyperviscosity Syndrome in Paraprotein Secreting Conditions Including Waldenstrom Macroglobulinemia

Frontiers in Oncology, 2020
Robert Cornell, Samuel Rubinstein, Rubinstein Samuel   +2 more
exaly  

Treatment of Waldenstrom's Macroglobulinemia with Rituximab: Prognostic Factors for Response and Progression

Leukemia and Lymphoma, 2004
Athanasios K Anagnostopoulos, Gerassimos Pangalis, Meletios Dimopoulos   +2 more
exaly  

A new era for Waldenstrom macroglobulinemia: MYD88 L265P

Blood, 2013
Steven Tréon, Zachary Hunter, Hunter Zachary R   +2 more
exaly